Overview

The Effect of Platelet Rich Plasma on Partial Thickness Rotator Cuff Tears: A Randomized Controlled Trial

Status:
Completed
Trial end date:
2019-06-06
Target enrollment:
0
Participant gender:
All
Summary
Randomized controlled trial examining platelet rich plasma versus corticosteroid injection in partial thickness rotator cuff tears or tendinopathy.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Calgary
Criteria
Inclusion Criteria:

- >18 years

- MRI or US evidence of supraspinatus tendinopathy or partial thickness tearing

- symptomatic for minimum of 3 months

- patient has exhausted a course of adequate conservative treatment (including but not
limited to home/out patient physical therapy, oral analgesics, and/or shoulder
injections)

Exclusion Criteria:

- prior surgical intervention on affected shoulder

- full thickness rotator cuff tear

- concomitant ipsilateral shoulder pathology (i.e. osteoarthritis, inflammatory
arthritis)

- confounding cervical neck pain or radiculopathy

- more than 3 previous CS injections

- a CS injection within 6 months of study intervention

- elite level athlete

- worker's compensation case

- litigation or secondary gain issues

- unwilling or unable to provide informed consent or complete study outcomes